Chapter 25. Clinical Trials with Ruboxistaurin

  1. Richard Donnelly MD, PhD, FRCP, FRACP1 and
  2. Edward Horton MD2
  1. Richard Donnelly

Published Online: 13 DEC 2007

DOI: 10.1002/9780470751503.ch25

Vascular Complications of Diabetes: Current Issues in Pathogenesis and Treatment, Second Edition

Vascular Complications of Diabetes: Current Issues in Pathogenesis and Treatment, Second Edition

How to Cite

Donnelly, R. (2005) Clinical Trials with Ruboxistaurin, in Vascular Complications of Diabetes: Current Issues in Pathogenesis and Treatment, Second Edition (eds R. Donnelly and E. Horton), Blackwell Publishing, Inc., Malden, Massachusetts, USA. doi: 10.1002/9780470751503.ch25

Editor Information

  1. 1

    Division of Vascular Medicine University of Nottingham The Medical School Derby DE22 3DT UK

  2. 2

    Joslin Diabetes Center One Joslin Place Boston MA 02215 USA

Publication History

  1. Published Online: 13 DEC 2007
  2. Published Print: 1 JAN 2005

ISBN Information

Print ISBN: 9781405127851

Online ISBN: 9780470751503

SEARCH

Keywords:

  • ruboxistaurin;
  • endothelial dysfunction;
  • diabetic retinopathy;
  • measurements;
  • ischaemia

Summary

This chapter contains section titled:

  • INTRODUCTION

  • RUBOXISTAURIN IMPROVES ENDOTHELIAL DYSFUNCTION

  • CLINICAL TRIALS OF RUBOXISTAURIN IN DIABETIC RETINOPATHY

  • CLINICAL TRIALS OF RUBOXISTAURIN IN DIABETIC PERIPHERAL NEUROPATHY

  • CLINICAL TRIALS OF RUBOXISTAURIN IN OTHER DIABETES-RELATED COMPLICATIONS